June 23, 2017 3:54 AM ET

Healthcare Providers and Services

Company Overview of DaVita Inc.

Company Overview

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). It operates through two divisions, DaVita Kidney Care and DaVita Medical Group. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers, as well as patient and physician focused integrated health care delive...

2000 16th Street

Denver, CO 80202

United States

Founded in 1994

70,300 Employees



Key Executives for DaVita Inc.

Chairman and Chief Executive Officer
Age: 60
Total Annual Compensation: $1.3M
Chief Executive Officer of Kidney Care
Age: 45
Total Annual Compensation: $865.4K
Chief Accounting Officer
Age: 54
Total Annual Compensation: $585.0K
Chief Legal Officer
Age: 48
Total Annual Compensation: $1.1M
Group Vice President of Purchasing and Public Affairs
Age: 57
Total Annual Compensation: $600.0K
Compensation as of Fiscal Year 2016.

DaVita Inc. Key Developments

DaVita Inc. Presents at Piper Jaffray 2017 Heartland Summit, Jun-15-2017

DaVita Inc. Presents at Piper Jaffray 2017 Heartland Summit, Jun-15-2017 . Venue: Minneapolis, Minnesota, United States. Speakers: Kent J. Thiry, Chairman, Chief Executive Officer and Chief Executive Officer of Davita Medical Group.

Robbins Arroyo LLP Files Class Action Complaint against DaVita Inc

Robbins Arroyo LLP announced that a class action complaint was filed against DaVita Inc. in the U.S. District Court for the District of Colorado. The complaint is brought on behalf of all purchasers of DaVita securities between August 5, 2015 and October 21, 2016, for alleged violations of the Securities Exchange Act of 1934 by DaVita's officers and directors. DaVita provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease. According to the complaint, DaVita purposefully steered patients into unnecessary private insurance plans in order to maximize profits by using the American Kidney Fund ("AKF") as a vehicle to facilitate its scheme, which resulted in illegally obtained revenues and profits. On August 18, 2016, the Centers for Medicare and Medicaid Services sent correspondence to DaVita for information regarding alleged steering of Medicare and Medicaid beneficiaries into other plans in order to earn higher reimbursement rates. On October 23, 2016, the St. Louis Post published an article that accused DaVita of steering clients to private insurers. On this news, DaVita's stock price fell $2.86 per share, or 4.69%, to close at $58.10 per share on October 24, 2016. Then, on January 6, 2017, The Wall Street Journal reported that the U.S. Attorney's Office for the District of Massachusetts had subpoenaed DaVita and the AKF seeking information relating to its charitable premium assistance.

DaVita Inc Introduces DaVita Health Solutions

DaVita Inc. announced it has formalized a new business, DaVita Health Solutions, to help care for the highest-risk, most clinically complex patients in the U.S. The DaVita Health Solutions care model expands primary care outside of the traditional doctor's office setting to meet patients when and where they need care most in the home, at a post-acute skilled nursing facility (SNF), or within a dialysis center for patients who suffer from end stage renal disease (ESRD). DaVita Health Solutions offers a comprehensive care suite that includes: House calls, meeting patients where they are: A physician-led program that provides primary care, behavioral health, palliative care, comprehensive wellness visits and complementary health care services to patients and their caregivers within the patient's home; Smoother transitions back home to families: A post-acute care program with employed SNFists who help patients experience smoother transitions home from a skilled nursing facility so they can spend more quality time with loved ones and may avoid return visits to the hospital; A dialysis center as the medical home: An integrated kidney care program that treats ESRD patients where they spend 12-15 hours per week and coordinates their care across doctors and specialists; 24x7 support and coordinated care: A physician-led, interdisciplinary clinical care team comprised of physicians, nurse practitioners, registered nurses, behavioral health and palliative care specialists, social workers, pharmacists and dietitians.

Similar Private Companies By Industry

Company Name Region
@ Home Medical, Inc. United States
@home approach, llc United States
@Home Care United States
1011 E. Pecan Grove Road, LLC United States
1104 Welsh Road Operations LLC United States

Recent Private Companies Transactions

May 4, 2017
DaVita Inc., Seven Dialysis Facilities in New Jersey and Texas
May 2, 2017
12 dialysis centers in the United States
March 28, 2017
Ownership Interest in Seven Clinics

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact DaVita Inc., please visit www.davita.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.